Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2016 (2016), Article ID 4094932, 4 pages
http://dx.doi.org/10.1155/2016/4094932
Research Article

Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification

1Departments of Pathology and Laboratory Medicine, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA
2Clinical Microbiology, Immunology and Virology Laboratories, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA
3Microbiology and Immunology, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA
4Internal Medicine, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA

Received 27 February 2015; Accepted 23 September 2015

Copyright © 2016 Michelle L. Grant et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. Zilberberg, A. F. Shorr, and M. H. Kollef, “Growth and geographic variation in hospitalizations with resistant infections, United States, 2000–2005,” Emerging Infectious Diseases, vol. 14, no. 11, pp. 1756–1758, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Wisplinghoff, T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond, “Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study,” Clinical Infectious Diseases, vol. 39, no. 3, pp. 309–317, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Pfaller and D. J. Diekema, “Epidemiology of invasive mycoses in North America,” Critical Reviews in Microbiology, vol. 36, no. 1, pp. 1–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. D. L. Horn, D. Neofytos, E. J. Anaissie et al., “Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry,” Clinical Infectious Diseases, vol. 48, no. 12, pp. 1695–1703, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Hope, A. Morton, and D. P. Eisen, “Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use,” Journal of Hospital Infection, vol. 50, no. 1, pp. 56–65, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. C. Arendrup, E. Dzajic, R. H. Jensen et al., “Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme,” Clinical Microbiology and Infection, vol. 19, no. 8, pp. E343–E353, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Morgan, M. I. Meltzer, B. D. Plikaytis et al., “Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance,” Infection Control and Hospital Epidemiology, vol. 26, no. 6, pp. 540–547, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Morrell, V. J. Fraser, and M. H. Kollef, “Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 9, pp. 3640–3645, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. P. G. Pappas, J. H. Rex, J. Lee et al., “A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients,” Clinical Infectious Diseases, vol. 37, no. 5, pp. 634–643, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. B. Wey, M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel, “Hospital-acquired candidemia. The attributable mortality and excess length of stay,” Archives of Internal Medicine, vol. 148, no. 12, pp. 2642–2645, 1988. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Pfaller, D. Neofytos, D. Diekema et al., “Epidemiology and outcomes of candidemia in 3648 patients: data from the prospective antifungal therapy (PATH Alliance®) registry, 2004–2008,” Diagnostic Microbiology and Infectious Disease, vol. 74, no. 4, pp. 323–331, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. K. W. Garey, M. Rege, M. P. Pai et al., “Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study,” Clinical Infectious Diseases, vol. 43, no. 1, pp. 25–31, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Datta, P. Rhee, E. Byrnes III et al., “Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility,” Journal of Clinical Microbiology, vol. 51, no. 9, pp. 3090–3093, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Almirante, D. Rodríguez, B. J. Park et al., “Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003,” Journal of Clinical Microbiology, vol. 43, no. 4, pp. 1829–1835, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. T. Griffin and K. E. Hanson, “Update on fungal diagnostics,” Current Infectious Disease Reports, vol. 16, no. 8, article 415, 2014. View at Publisher · View at Google Scholar
  16. E. J. Won, J. H. Shin, M.-N. Kim et al., “Evaluation of the BD Phoenix system for identification of a wide spectrum of clinically important yeast species: a comparison with Vitek 2-YST,” Diagnostic Microbiology and Infectious Disease, vol. 79, no. 4, pp. 477–480, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Posteraro, A. Ruggeri, E. De Carolis et al., “Comparative evaluation of BD phoenix and Vitek 2 systems for species identification of common and uncommon pathogenic yeasts,” Journal of Clinical Microbiology, vol. 51, no. 11, pp. 3841–3845, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. J. K. Wadlin, G. Hanko, R. Stewart, J. Pape, and I. Nachamkin, “Comparison of three commercial systems for identification of yeasts commonly isolated in the clinical microbiology laboratory,” Journal of Clinical Microbiology, vol. 37, no. 6, pp. 1967–1970, 1999. View at Google Scholar · View at Scopus
  19. P. E. Verweij, I. M. Breuker, A. J. M. M. Rijs, and J. F. G. M. Meis, “Comparative study of seven commercial yeast identification systems,” Journal of Clinical Pathology, vol. 52, no. 4, pp. 271–273, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Sanguinetti, R. Porta, M. Sali et al., “Evaluation of VITEK 2 and RapID Yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratory,” Journal of Clinical Microbiology, vol. 45, no. 4, pp. 1343–1346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Moghaddas, A. L. Truant, C. Jordan, and H. R. Buckley, “Evaluation of the RapID Yeast Plus System for the identification of yeast,” Diagnostic Microbiology and Infectious Disease, vol. 35, no. 4, pp. 271–273, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. J. S. Heelan, E. Sotomayor, K. Coon, and J. B. D'Arezzo, “Comparison of the rapid yeast plus panel with the API20C yeast system for identification of clinically significant isolates of Candida species,” Journal of Clinical Microbiology, vol. 36, no. 5, pp. 1443–1445, 1998. View at Google Scholar · View at Scopus
  23. U. Gayibova, B. Dalyan Cilo, H. Agca, and B. Ener, “Comparison of Phoenix Yeast ID Panel and API(R) ID 32C commercial systems for the identification of Candida species isolated from clinical samples,” Mikrobiyoloji Bulteni, vol. 48, no. 3, pp. 438–448, 2014. View at Google Scholar
  24. E. M. Shankar, N. Kumarasamy, D. Bella et al., “Pneumonia and pleural effusion due to Cryptococcus laurentii in a clinically proven case of AIDS,” Canadian Respiratory Journal, vol. 13, no. 5, pp. 275–278, 2006. View at Publisher · View at Google Scholar · View at Scopus